CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: imipramine
Accession: CHEBI:47499
browse the term
Definition: A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
Synonyms: exact_synonym: 3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine
related_synonym: 10,11-dihydro-N,N-dimethyl-5H-dibenz[b,f]azepine-5-propanamine; 3-(5H-DIBENZO[B,F]AZEPIN-5-YL)-N,N-DIMETHYLPROPAN-1-AMINE; 5-[3-(dimethylamino)propyl]-10,11-dihydro-5H-dibenz[b,f]azepine; Antideprin; Formula=C19H24N2; Imipramin; InChI=1S/C19H24N2/c1-20(2)14-7-15-21-18-10-5-3-8-16(18)12-13-17-9-4-6-11-19(17)21/h3-6,8-11H,7,12-15H2,1-2H3; InChIKey=BCGWQEUPMDMJNV-UHFFFAOYSA-N; Irmin; Melipramine; N-(gamma-dimethylaminopropyl)iminodibenzyl; SMILES=CN(C)CCCN1c2ccccc2CCc2ccccc12; imipraminum; imizine
alt_id: CHEBI:47498; CHEBI:5881
xref: Beilstein:256892; CAS:50-49-7; DrugBank:DB00458; Drug_Central:1427; Gmelin:1572523; HMDB:HMDB0001848; KEGG:C07049; KEGG:D08070; LINCS:LSM-2852
xref_mesh: MESH:D007099
xref: PDBeChem:IXX; PMID:20825390; Patent:US2554736; Reaxys:256892; Wikipedia:Imipramine
G
Aadat
aminoadipate aminotransferase
affects expression
ISO
Imipramine affects the expression of AADAT mRNA
CTD
PMID:18355885
NCBI chr 8:60,958,877...60,998,711
Ensembl chr 8:60,958,966...60,998,711
G
Abcb1a
ATP-binding cassette, sub-family B member 1A
affects expression
ISO
Imipramine affects the expression of ABCB1 mRNA
CTD
PMID:18355885
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
G
Ace2
angiotensin converting enzyme 2
decreases expression
ISO
Imipramine results in decreased expression of ACE2 mRNA
CTD
PMID:32808185
NCBI chr X:162,922,338...162,971,414
Ensembl chr X:162,922,328...162,971,416
G
Ache
acetylcholinesterase
multiple interactions increases activity decreases activity
ISO EXP
Imipramine inhibits the reaction [asoxime chloride inhibits the reaction [cyclohexyl methylphosphonofluoridate results in decreased activity of ACHE protein]]; Imipramine inhibits the reaction [asoxime chloride inhibits the reaction [Sarin results in decreased activity of ACHE protein]]; Imipramine inhibits the reaction [Obidoxime Chloride metabolite results in decreased activity of ACHE protein]; Imipramine promotes the reaction [Obidoxime Chloride inhibits the reaction [Sarin results in decreased activity of ACHE protein]] Imipramine results in increased activity of ACHE protein Imipramine results in decreased activity of ACHE protein
CTD
PMID:25522658 PMID:29614332
NCBI chr 5:137,286,516...137,292,728
Ensembl chr 5:137,285,781...137,292,728
G
Adrb1
adrenergic receptor, beta 1
multiple interactions decreases activity
ISO
[Imipramine co-treated with Idazoxan] results in decreased activity of ADRB1 protein; [Imipramine co-treated with Yohimbine] results in decreased activity of ADRB1 protein Imipramine results in decreased activity of ADRB1 protein
CTD
PMID:2868116
NCBI chr19:56,710,549...56,713,582
Ensembl chr19:56,710,631...56,721,545
G
Adrb2
adrenergic receptor, beta 2
decreases expression
ISO
Imipramine results in decreased expression of ADRB2 protein
CTD
PMID:10618463
NCBI chr18:62,310,784...62,313,052
Ensembl chr18:62,310,887...62,313,030
G
Alb
albumin
affects binding
ISO
Imipramine binds to ALB protein
CTD
PMID:20956006
NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
G
Aldh1a1
aldehyde dehydrogenase family 1, subfamily A1
affects expression
ISO
Imipramine affects the expression of ALDH1A1 mRNA
CTD
PMID:18355885
NCBI chr19:20,469,947...20,620,827
Ensembl chr19:20,470,079...20,620,829
G
Ap2m1
adaptor-related protein complex 2, mu 1 subunit
multiple interactions
EXP
Imipramine inhibits the reaction [NTRK2 protein binds to AP2M1 protein]
CTD
PMID:31631060
NCBI chr16:20,354,230...20,363,659
Ensembl chr16:20,354,228...20,363,659
G
Apoa4
apolipoprotein A-IV
affects expression
ISO
Imipramine affects the expression of APOA4 mRNA
CTD
PMID:18355885
NCBI chr 9:46,152,142...46,154,756
Ensembl chr 9:46,151,994...46,154,757
G
Arg1
arginase, liver
multiple interactions
EXP
Imipramine affects the reaction [caryophyllene inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in decreased expression of ARG1 protein]]
CTD
PMID:30620895
NCBI chr10:24,791,105...24,803,368
Ensembl chr10:24,791,119...24,803,382
G
Asah1
N-acylsphingosine amidohydrolase 1
increases expression
ISO
Imipramine results in increased expression of ASAH1 mRNA
CTD
PMID:15342952 PMID:17567588
NCBI chr 8:41,793,683...41,850,681
Ensembl chr 8:41,793,234...41,827,810
G
Asns
asparagine synthetase
increases expression
ISO
Imipramine results in increased expression of ASNS mRNA
CTD
PMID:15342952 PMID:17567588
NCBI chr 6:7,675,169...7,693,209
Ensembl chr 6:7,675,169...7,693,254
G
Bdnf
brain derived neurotrophic factor
increases expression affects expression multiple interactions
EXP ISO
Imipramine results in increased expression of BDNF mRNA Imipramine affects the expression of BDNF protein Rolipram promotes the reaction [Imipramine results in increased expression of BDNF mRNA]
CTD
PMID:8601816 PMID:15157811 PMID:17617388 PMID:17950272
NCBI chr 2:109,505,045...109,557,388
Ensembl chr 2:109,505,045...109,557,352
G
Bhmt
betaine-homocysteine methyltransferase
affects expression
ISO
Imipramine affects the expression of BHMT mRNA
CTD
PMID:18355885
NCBI chr13:93,753,399...93,774,266
Ensembl chr13:93,753,183...93,774,469
G
Casp3
caspase 3
multiple interactions increases activity
ISO
Imipramine results in increased cleavage of and results in increased activity of CASP3 protein; Palmitic Acid promotes the reaction [Imipramine results in increased activity of CASP3 protein]
CTD
PMID:10487422 PMID:22700542
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
G
Casp7
caspase 7
increases activity multiple interactions
ISO
Imipramine results in increased activity of CASP7 protein Palmitic Acid promotes the reaction [Imipramine results in increased activity of CASP7 protein]
CTD
PMID:22700542
NCBI chr19:56,382,640...56,430,780
Ensembl chr19:56,385,561...56,430,776
G
Casp8
caspase 8
multiple interactions
EXP
Imipramine inhibits the reaction [lead acetate results in increased activity of CASP8 protein]
CTD
PMID:22033380
NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
G
Cat
catalase
affects activity multiple interactions
EXP ISO
Imipramine affects the activity of CAT protein Imipramine inhibits the reaction [Streptozocin results in increased activity of CAT protein]
CTD
PMID:19798453 PMID:34352274
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
G
Cdkn2c
cyclin dependent kinase inhibitor 2C
affects expression
ISO
Imipramine affects the expression of CDKN2C mRNA
CTD
PMID:18355885
NCBI chr 4:109,518,073...109,523,953
Ensembl chr 4:109,518,073...109,524,386
G
Ces2h
carboxylesterase 2H
affects expression
ISO
Imipramine affects the expression of CES2 mRNA
CTD
PMID:18355885
NCBI chr 8:105,727,462...105,747,042
Ensembl chr 8:105,727,485...105,747,810
G
Cmtm6
CKLF-like MARVEL transmembrane domain containing 6
affects expression
ISO
Imipramine affects the expression of CMTM6 mRNA
CTD
PMID:18355885
NCBI chr 9:114,560,184...114,578,412
Ensembl chr 9:114,560,184...114,578,412
G
Cnr1
cannabinoid receptor 1
decreases expression
ISO
Imipramine results in decreased expression of CNR1 protein
CTD
PMID:28866072
NCBI chr 4:33,923,171...33,948,831
Ensembl chr 4:33,924,593...33,948,831
G
Cnr2
cannabinoid receptor 2
increases expression
ISO
Imipramine results in increased expression of CNR2 protein
CTD
PMID:28866072
NCBI chr 4:135,622,500...135,647,530
Ensembl chr 4:135,622,705...135,647,518
G
Cpped1
calcineurin-like phosphoesterase domain containing 1
affects expression
ISO
Imipramine affects the expression of CPPED1 mRNA
CTD
PMID:18355885
NCBI chr16:11,621,546...11,727,377
Ensembl chr16:11,621,585...11,727,309
G
Creb1
cAMP responsive element binding protein 1
increases expression increases phosphorylation multiple interactions
ISO EXP
Imipramine results in increased expression of CREB1 mRNA Imipramine results in increased phosphorylation of CREB1 protein Rolipram promotes the reaction [Imipramine results in increased expression of CREB1 mRNA]
CTD
PMID:8601816 PMID:22396798
NCBI chr 1:64,571,963...64,643,707
Ensembl chr 1:64,571,804...64,643,707
G
Crem
cAMP responsive element modulator
affects expression
ISO
Imipramine affects the expression of CREM mRNA
CTD
PMID:18355885
NCBI chr18:3,263,181...3,337,688
Ensembl chr18:3,266,048...3,337,748
G
Crh
corticotropin releasing hormone
affects activity
ISO
Imipramine affects the activity of CRH protein
CTD
PMID:2553044
NCBI chr 3:19,747,565...19,749,560
Ensembl chr 3:19,747,565...19,749,560
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
affects metabolic processing increases metabolic processing multiple interactions
ISO
CYP1A2 protein affects the metabolism of Imipramine CYP1A2 protein results in increased metabolism of Imipramine CYP1A2 protein results in decreased methylation of and results in increased activity of Imipramine; Imipramine inhibits the reaction [resveratrol results in decreased activity of CYP1A2 protein]; Organophosphorus Compounds inhibits the reaction [CYP1A2 protein results in decreased methylation of and results in increased activity of Imipramine]
CTD
PMID:11714871 PMID:15286053 PMID:15922009
NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
G
Cyp2a22
cytochrome P450, family 2, subfamily a, polypeptide 22
affects expression
ISO
Imipramine affects the expression of CYP2A1 mRNA
CTD
PMID:18355885
NCBI chr 7:26,631,564...26,638,838
Ensembl chr 7:26,631,056...26,638,809
G
Cyp2c38
cytochrome P450, family 2, subfamily c, polypeptide 38
affects metabolic processing multiple interactions
ISO
CYP2C19 protein affects the metabolism of Imipramine CYP2C19 protein results in decreased methylation of and results in increased activity of Imipramine; Organophosphorus Compounds inhibits the reaction [CYP2C19 protein results in decreased methylation of and results in increased activity of Imipramine]
CTD
PMID:15286053 PMID:15922009
NCBI chr19:39,379,109...39,451,519
Ensembl chr19:39,378,000...39,451,519
G
Cyp2d22
cytochrome P450, family 2, subfamily d, polypeptide 22
affects metabolic processing
ISO
CYP2D6 protein affects the metabolism of Imipramine
CTD
PMID:15286053
NCBI chr15:82,254,728...82,264,461
Ensembl chr15:82,254,728...82,264,461
G
Cyp4f14
cytochrome P450, family 4, subfamily f, polypeptide 14
affects expression
ISO
Imipramine affects the expression of CYP4F2 mRNA
CTD
PMID:18355885
NCBI chr17:33,122,331...33,136,353
Ensembl chr17:33,124,044...33,136,316
G
Dcaf8
DDB1 and CUL4 associated factor 8
affects expression
ISO
Imipramine affects the expression of DCAF8 mRNA
CTD
PMID:18355885
NCBI chr 1:171,975,574...172,023,959
Ensembl chr 1:171,975,651...172,024,572
G
Depp1
DEPP1 autophagy regulator
increases expression
ISO
Imipramine results in increased expression of DEPP1 mRNA
CTD
PMID:15342952 PMID:17567588
NCBI chr 6:116,627,645...116,629,808
Ensembl chr 6:116,627,570...116,629,755
G
Dnajc5
DnaJ heat shock protein family (Hsp40) member C5
increases expression
ISO
Imipramine results in increased expression of DNAJC5 mRNA; Imipramine results in increased expression of DNAJC5 protein
CTD
PMID:11257428
NCBI chr 2:181,162,141...181,194,679
Ensembl chr 2:181,162,278...181,196,926
G
Eif4b
eukaryotic translation initiation factor 4B
affects expression
ISO
Imipramine affects the expression of EIF4B mRNA
CTD
PMID:18355885
NCBI chr15:101,982,208...102,005,608
Ensembl chr15:101,982,208...102,005,608
G
Ephx1
epoxide hydrolase 1, microsomal
affects expression
ISO
Imipramine affects the expression of EPHX1 mRNA
CTD
PMID:18355885
NCBI chr 1:180,817,121...180,845,134
Ensembl chr 1:180,803,775...180,848,469
G
Erp29
endoplasmic reticulum protein 29
affects expression
ISO
Imipramine affects the expression of ERP29 mRNA
CTD
PMID:18355885
NCBI chr 5:121,582,816...121,590,537
Ensembl chr 5:121,566,653...121,590,569
G
Fabp1
fatty acid binding protein 1, liver
increases expression
ISO
Imipramine results in increased expression of FABP1 mRNA
CTD
PMID:15342952 PMID:17567588
NCBI chr 6:71,176,863...71,182,018
Ensembl chr 6:71,176,811...71,182,007
G
Fndc4
fibronectin type III domain containing 4
increases expression
ISO
Imipramine results in increased expression of FNDC4 mRNA
CTD
PMID:15342952 PMID:17567588
NCBI chr 5:31,449,589...31,453,279
Ensembl chr 5:31,449,586...31,453,424
G
Fos
FBJ osteosarcoma oncogene
decreases expression
ISO
Imipramine results in decreased expression of FOS mRNA
CTD
PMID:7612155
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
G
Gap43
growth associated protein 43
decreases expression
ISO
Imipramine results in decreased expression of GAP43 mRNA
CTD
PMID:17950272
NCBI chr16:42,068,915...42,161,014
Ensembl chr16:42,068,805...42,161,014
G
Gckr
glucokinase regulatory protein
affects expression
ISO
Imipramine affects the expression of GCKR mRNA
CTD
PMID:18355885
NCBI chr 5:31,454,594...31,484,646
Ensembl chr 5:31,454,787...31,484,658
G
Gdpd3
glycerophosphodiester phosphodiesterase domain containing 3
increases expression
ISO
Imipramine results in increased expression of GDPD3 mRNA
CTD
PMID:15342952 PMID:17567588
NCBI chr 7:126,365,586...126,374,817
Ensembl chr 7:126,365,506...126,374,821
G
Gls2
glutaminase 2 (liver, mitochondrial)
affects expression
ISO
Imipramine affects the expression of GLS2 mRNA
CTD
PMID:18355885
NCBI chr10:128,030,504...128,045,873
Ensembl chr10:128,030,326...128,045,873
G
Got2
glutamatic-oxaloacetic transaminase 2, mitochondrial
affects expression
ISO
Imipramine affects the expression of GOT2 mRNA
CTD
PMID:18355885
NCBI chr 8:96,590,761...96,615,029
Ensembl chr 8:96,590,762...96,615,175
G
Grb14
growth factor receptor bound protein 14
affects expression
ISO
Imipramine affects the expression of GRB14 mRNA
CTD
PMID:18355885
NCBI chr 2:64,742,820...64,853,143
Ensembl chr 2:64,742,820...64,855,331
G
Grin1
glutamate receptor, ionotropic, NMDA1 (zeta 1)
decreases expression
ISO
Imipramine results in decreased expression of GRIN1 mRNA
CTD
PMID:34748853
NCBI chr 2:25,181,189...25,209,199
Ensembl chr 2:25,181,193...25,209,199
G
Gstp1
glutathione S-transferase, pi 1
decreases activity
ISO
Imipramine results in decreased activity of GSTP1 protein
CTD
PMID:15094841
NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985
G
Hal
histidine ammonia lyase
affects expression
ISO
Imipramine affects the expression of HAL mRNA
CTD
PMID:18355885
NCBI chr10:93,324,630...93,352,623
Ensembl chr10:93,324,630...93,355,166
G
Hdac5
histone deacetylase 5
increases expression
EXP
Imipramine results in increased expression of HDAC5 mRNA
CTD
PMID:17988634
NCBI chr11:102,085,244...102,120,968
Ensembl chr11:102,085,258...102,120,992
G
Hmbs
hydroxymethylbilane synthase
decreases activity
ISO
Imipramine results in decreased activity of HMBS protein
CTD
PMID:10416826
NCBI chr 9:44,247,645...44,255,525
Ensembl chr 9:44,247,636...44,255,525
G
Hmgb2
high mobility group box 2
affects expression
ISO
Imipramine affects the expression of HMGB2 mRNA
CTD
PMID:18355885
NCBI chr 8:57,964,877...57,969,033
Ensembl chr 8:57,964,941...57,969,033
G
Hmgcs1
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1
increases expression
ISO
Imipramine results in increased expression of HMGCS1 mRNA
CTD
PMID:16324787
NCBI chr13:120,151,887...120,169,796
Ensembl chr13:120,151,915...120,169,796
G
Hpn
hepsin
increases expression
ISO
Imipramine results in increased expression of HPN mRNA
CTD
PMID:15342952 PMID:17567588
NCBI chr 7:30,798,150...30,814,751
Ensembl chr 7:30,798,150...30,814,715
G
Hsf1
heat shock factor 1
decreases activity
ISO
Imipramine results in decreased activity of HSF1 protein
CTD
PMID:34170685
NCBI chr15:76,361,562...76,385,355
Ensembl chr15:76,361,622...76,386,113
G
Hspa8
heat shock protein 8
increases expression
ISO
Imipramine results in increased expression of HSPA8 mRNA alternative form; Imipramine results in increased expression of HSPA8 protein alternative form
CTD
PMID:10425221
NCBI chr 9:40,712,572...40,716,498
Ensembl chr 9:40,712,280...40,721,383
G
Htr1a
5-hydroxytryptamine (serotonin) receptor 1A
affects expression
ISO
Imipramine affects the expression of HTR1A mRNA
CTD
PMID:17617388
NCBI chr13:105,580,040...105,584,630
Ensembl chr13:105,580,147...105,584,630
G
Htr2a
5-hydroxytryptamine (serotonin) receptor 2A
decreases expression
ISO
Imipramine results in decreased expression of HTR2A
CTD
PMID:2553044
NCBI chr14:74,878,314...74,944,299
Ensembl chr14:74,878,280...74,946,934
G
Il10
interleukin 10
multiple interactions
EXP
Imipramine affects the reaction [caryophyllene promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of IL10 protein]]
CTD
PMID:30620895
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
G
Il1b
interleukin 1 beta
multiple interactions
EXP
Imipramine affects the reaction [caryophyllene inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of IL1B protein]]; Imipramine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of IL1B protein]
CTD
PMID:30620895
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il33
interleukin 33
affects expression
ISO
Imipramine affects the expression of IL33 mRNA
CTD
PMID:18355885
NCBI chr19:29,902,513...29,938,118
Ensembl chr19:29,902,514...29,938,118
G
Inhbe
inhibin beta-E
increases expression
ISO
Imipramine results in increased expression of INHBE mRNA
CTD
PMID:15342952 PMID:17567588
NCBI chr10:127,185,271...127,187,717
Ensembl chr10:127,184,726...127,190,280
G
Kcnh1
potassium voltage-gated channel, subfamily H (eag-related), member 1
multiple interactions
ISO
Imipramine binds to and results in decreased activity of KCNH1 protein
CTD
PMID:18497958
NCBI chr 1:191,871,759...192,192,467
Ensembl chr 1:191,873,082...192,192,467
G
Kcnh2
potassium voltage-gated channel, subfamily H (eag-related), member 2
multiple interactions decreases activity decreases localization
ISO
Imipramine binds to and results in decreased activity of KCNH2 protein; Imipramine inhibits the reaction [KCNH2 protein results in increased transport of Thallium] Imipramine results in decreased activity of KCNH2 protein Imipramine results in decreased localization of KCNH2 protein
CTD
PMID:15272206 PMID:19583963 PMID:21158687 PMID:21525004 PMID:24052561
NCBI chr 5:24,524,583...24,556,671
Ensembl chr 5:24,524,587...24,556,602
G
Kcnn2
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2
decreases activity
ISO
Imipramine results in decreased activity of KCNN2 protein
CTD
PMID:10915830
NCBI chr18:45,401,754...45,818,954
Ensembl chr18:45,401,927...45,818,950
G
Lox
lysyl oxidase
affects expression
ISO
Imipramine affects the expression of LOX mRNA
CTD
PMID:18355885
NCBI chr18:52,649,132...52,662,939
Ensembl chr18:52,649,139...52,662,939
G
Lss
lanosterol synthase
increases expression
ISO
Imipramine results in increased expression of LSS mRNA
CTD
PMID:15342952 PMID:17567588
NCBI chr10:76,367,303...76,392,973
Ensembl chr10:76,367,422...76,392,972
G
Macroh2a1
macroH2A.1 histone
affects expression
ISO
Imipramine affects the expression of MACROH2A1 mRNA
CTD
PMID:18355885
NCBI chr13:56,221,435...56,283,439
Ensembl chr13:56,221,432...56,284,174
G
Manba
mannosidase, beta A, lysosomal
affects expression
ISO
Imipramine affects the expression of MANBA mRNA
CTD
PMID:18355885
NCBI chr 3:135,191,367...135,277,165
Ensembl chr 3:135,191,372...135,277,165
G
Mapk1
mitogen-activated protein kinase 1
multiple interactions
ISO
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Imipramine binds to and results in increased activity of MAPK1 protein]; Imipramine binds to and results in increased activity of MAPK1 protein
CTD
PMID:20484120
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
G
Mapk3
mitogen-activated protein kinase 3
multiple interactions
ISO
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Imipramine binds to and results in increased activity of MAPK3 protein]; Imipramine binds to and results in increased activity of MAPK3 protein
CTD
PMID:20484120
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
G
Mlx
MAX-like protein X
affects expression
ISO
Imipramine affects the expression of MLX mRNA
CTD
PMID:18355885
NCBI chr11:100,978,116...100,983,033
Ensembl chr11:100,978,103...100,983,033
G
Mrps18b
mitochondrial ribosomal protein S18B
affects expression
ISO
Imipramine affects the expression of MRPS18B mRNA
CTD
PMID:18355885
NCBI chr17:36,221,272...36,227,332
Ensembl chr17:36,221,271...36,227,281
G
Msmo1
methylsterol monoxygenase 1
affects expression
ISO
Imipramine affects the expression of MSMO1 mRNA
CTD
PMID:18355885
NCBI chr 8:65,171,157...65,186,822
Ensembl chr 8:65,171,173...65,186,826
G
Nr0b2
nuclear receptor subfamily 0, group B, member 2
increases expression
ISO
Imipramine results in increased expression of NR0B2 mRNA
CTD
PMID:15342952
NCBI chr 4:133,280,687...133,283,997
Ensembl chr 4:133,280,687...133,283,847
G
Nrep
neuronal regeneration related protein
affects expression
ISO
Imipramine affects the expression of NREP mRNA
CTD
PMID:18355885
NCBI chr18:33,570,072...33,597,444
Ensembl chr18:33,570,072...33,597,082
G
Ntrk2
neurotrophic tyrosine kinase, receptor, type 2
multiple interactions increases phosphorylation
EXP
Imipramine inhibits the reaction [NTRK2 protein binds to AP2M1 protein]; Imipramine promotes the reaction [NTRK2 protein binds to PLCG1 protein modified form]; Imipramine results in increased phosphorylation of and results in increased activity of NTRK2 protein Imipramine results in increased phosphorylation of NTRK2 protein
CTD
PMID:21666748 PMID:22396798 PMID:31631060
NCBI chr13:58,954,363...59,281,782
Ensembl chr13:58,954,383...59,281,784
G
Nupr1
nuclear protein transcription regulator 1
increases expression
ISO
Imipramine results in increased expression of NUPR1 mRNA
CTD
PMID:15342952 PMID:17567588
NCBI chr 7:126,222,418...126,224,642
Ensembl chr 7:126,222,421...126,230,033
G
Oaf
out at first homolog
affects expression
ISO
Imipramine affects the expression of OAF mRNA
CTD
PMID:18355885
NCBI chr 9:43,132,575...43,151,113
Ensembl chr 9:43,132,532...43,151,208
G
Orm2
orosomucoid 2
multiple interactions affects binding
ISO
Chlorpromazine inhibits the reaction [Imipramine binds to ORM2 protein alternative form]; Dipyridamole inhibits the reaction [Imipramine binds to ORM2 protein alternative form]; Disopyramide inhibits the reaction [Imipramine binds to ORM2 protein alternative form]; Lidocaine inhibits the reaction [Imipramine binds to ORM2 protein alternative form]; Methadone inhibits the reaction [Imipramine binds to ORM2 protein alternative form]; Progesterone inhibits the reaction [Imipramine binds to ORM2 protein alternative form]
CTD
PMID:8946472
NCBI chr 4:63,280,543...63,284,114
Ensembl chr 4:63,280,686...63,284,115
G
Parp1
poly (ADP-ribose) polymerase family, member 1
increases cleavage
ISO
Imipramine results in increased cleavage of PARP1 protein
CTD
PMID:10487422
NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
G
Pcx
pyruvate carboxylase
affects expression
ISO
Imipramine affects the expression of PC mRNA
CTD
PMID:18355885
NCBI chr19:4,560,500...4,671,780
Ensembl chr19:4,560,500...4,671,780
G
Pecr
peroxisomal trans-2-enoyl-CoA reductase
affects expression
ISO
Imipramine affects the expression of PECR mRNA
CTD
PMID:18355885
NCBI chr 1:72,298,331...72,323,480
Ensembl chr 1:72,298,326...72,323,473
G
Plcg1
phospholipase C, gamma 1
multiple interactions
EXP
Imipramine promotes the reaction [NTRK2 protein binds to PLCG1 protein modified form]
CTD
PMID:22396798
NCBI chr 2:160,573,230...160,617,680
Ensembl chr 2:160,573,220...160,617,680
G
Pomc
pro-opiomelanocortin-alpha
multiple interactions
ISO
Imipramine inhibits the reaction [Buspirone results in increased expression of POMC protein]
CTD
PMID:19762159
NCBI chr12:4,004,945...4,010,643
Ensembl chr12:4,004,951...4,010,642
G
Por
cytochrome p450 oxidoreductase
affects expression
ISO
Imipramine affects the expression of POR mRNA
CTD
PMID:18355885
NCBI chr 5:135,698,894...135,764,180
Ensembl chr 5:135,698,887...135,764,180
G
Ppp2ca
protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform
multiple interactions
ISO
Imipramine inhibits the reaction [Ethanol results in increased activity of PPP2CA protein]
CTD
PMID:20224005
NCBI chr11:51,989,651...52,013,576
Ensembl chr11:51,989,508...52,018,605
G
Rbl2
RB transcriptional corepressor like 2
affects expression
ISO
Imipramine affects the expression of RBL2 mRNA
CTD
PMID:18355885
NCBI chr 8:91,796,685...91,850,472
Ensembl chr 8:91,796,685...91,850,472
G
Scd2
stearoyl-Coenzyme A desaturase 2
increases expression
ISO
Imipramine results in increased expression of SCD mRNA
CTD
PMID:16324787
NCBI chr19:44,282,115...44,295,303
Ensembl chr19:44,282,113...44,295,303
G
Serpina3b
serine (or cysteine) peptidase inhibitor, clade A, member 3B
increases expression
ISO
Imipramine results in increased expression of SERPINA3 mRNA
CTD
PMID:15342952 PMID:17567588
NCBI chr12:104,094,245...104,105,805
Ensembl chr12:104,094,255...104,105,804
G
Serpini1
serine (or cysteine) peptidase inhibitor, clade I, member 1
increases expression
ISO
Imipramine results in increased expression of SERPINI1 mRNA
CTD
PMID:16637596
NCBI chr 3:75,464,800...75,549,830
Ensembl chr 3:75,464,854...75,550,802
G
Sh3gl3
SH3-domain GRB2-like 3
affects expression
ISO
Imipramine affects the expression of SH3GL3 mRNA
CTD
PMID:18355885
NCBI chr 7:81,824,581...81,956,618
Ensembl chr 7:81,823,588...81,956,627
G
Shank2
SH3 and multiple ankyrin repeat domains 2
decreases expression
ISO
Imipramine results in decreased expression of SHANK2 mRNA
CTD
PMID:34748853
NCBI chr 7:143,531,819...143,979,780
Ensembl chr 7:143,555,665...143,978,231
G
Slc22a1
solute carrier family 22 (organic cation transporter), member 1
multiple interactions
ISO
Imipramine inhibits the reaction [SLC22A1 protein results in increased uptake of Metformin]; Imipramine inhibits the reaction [SLC22A1 protein results in increased uptake of Quercetin]; Imipramine inhibits the reaction [SLC22A1 protein results in increased uptake of Tetraethylammonium]
CTD
PMID:24947867 PMID:25106415
NCBI chr17:12,867,761...12,894,725
Ensembl chr17:12,867,756...12,894,716
G
Slc22a2
solute carrier family 22 (organic cation transporter), member 2
multiple interactions
ISO
Imipramine inhibits the reaction [SLC22A2 protein polymorphism results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]; Imipramine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
CTD
PMID:21599003
NCBI chr17:12,803,076...12,847,376
Ensembl chr17:12,803,019...12,847,375
G
Slc22a3
solute carrier family 22 (organic cation transporter), member 3
multiple interactions
ISO
Imipramine inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium analog]; Imipramine inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]; Imipramine inhibits the reaction [SLC22A3 protein results in increased uptake of Metformin]
CTD
PMID:10966924 PMID:21697722
NCBI chr17:12,638,859...12,726,591
Ensembl chr17:12,637,847...12,726,591
G
Slc2a3
solute carrier family 2 (facilitated glucose transporter), member 3
decreases expression
ISO
Imipramine results in decreased expression of SLC2A3 mRNA
CTD
PMID:15342952 PMID:17567588
NCBI chr 6:122,704,783...122,779,149
Ensembl chr 6:122,704,768...122,778,599
G
Slc47a1
solute carrier family 47, member 1
decreases activity multiple interactions
ISO
Imipramine results in decreased activity of SLC47A1 protein Imipramine inhibits the reaction [SLC47A1 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
CTD
PMID:16928787 PMID:21599003
NCBI chr11:61,234,226...61,269,668
Ensembl chr11:61,234,227...61,269,171
G
Slc6a4
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
decreases activity
ISO
Imipramine results in decreased activity of SLC6A4 protein
CTD
PMID:18561912
NCBI chr11:76,889,423...76,923,169
Ensembl chr11:76,889,429...76,923,166
G
Slc6a6
solute carrier family 6 (neurotransmitter transporter, taurine), member 6
affects expression
ISO
Imipramine affects the expression of SLC6A6 mRNA
CTD
PMID:18355885
NCBI chr 6:91,661,031...91,736,044
Ensembl chr 6:91,661,034...91,736,047
G
Slco1a4
solute carrier organic anion transporter family, member 1a4
affects expression
ISO
Imipramine affects the expression of SLCO1A4 mRNA
CTD
PMID:18355885
NCBI chr 6:141,751,164...141,802,011
Ensembl chr 6:141,751,166...141,801,925
G
Srebf1
sterol regulatory element binding transcription factor 1
multiple interactions
ISO
Imipramine results in increased cleavage of and results in increased activity of SREBF1 protein
CTD
PMID:16324787
NCBI chr11:60,089,910...60,113,407
Ensembl chr11:60,089,915...60,113,407
G
Srebf2
sterol regulatory element binding factor 2
multiple interactions
ISO
Imipramine results in increased cleavage of and results in increased activity of SREBF2 protein
CTD
PMID:16324787
NCBI chr15:82,031,455...82,089,580
Ensembl chr15:82,031,382...82,089,580
G
St13
suppression of tumorigenicity 13
affects expression
ISO
Imipramine affects the expression of ST13 mRNA
CTD
PMID:18355885
NCBI chr15:81,247,869...81,284,278
Ensembl chr15:81,247,870...81,284,278
G
Stbd1
starch binding domain 1
affects expression
ISO
Imipramine affects the expression of STBD1 mRNA
CTD
PMID:18355885
NCBI chr 5:92,750,910...92,754,438
Ensembl chr 5:92,750,900...92,754,438
G
Stmn1
stathmin 1
affects expression
ISO
Imipramine affects the expression of STMN1 mRNA
CTD
PMID:18355885
NCBI chr 4:134,195,631...134,201,154
Ensembl chr 4:134,195,631...134,201,154
G
Tac1
tachykinin 1
decreases expression
ISO
Imipramine results in decreased expression of TAC1 protein
CTD
PMID:8955926
NCBI chr 6:7,555,061...7,562,978
Ensembl chr 6:7,554,879...7,565,834
G
Tagln
transgelin
decreases expression
ISO
Imipramine results in decreased expression of TAGLN mRNA
CTD
PMID:15342952 PMID:17567588
NCBI chr 9:45,840,926...45,847,356
Ensembl chr 9:45,840,917...45,847,356
G
Tex261
testis expressed gene 261
affects expression
ISO
Imipramine affects the expression of TEX261 mRNA
CTD
PMID:18355885
NCBI chr 6:83,745,863...83,752,804
Ensembl chr 6:83,745,867...83,752,795
G
Timm10b
translocase of inner mitochondrial membrane 10B
affects expression
ISO
Imipramine affects the expression of TIMM10B mRNA
CTD
PMID:18355885
NCBI chr 7:105,289,652...105,304,955
Ensembl chr 7:105,289,263...105,292,844 Ensembl chr 7:105,289,263...105,292,844
G
Tnf
tumor necrosis factor
multiple interactions
EXP ISO
Imipramine affects the reaction [caryophyllene inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of TNF protein]]; Imipramine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of TNF protein]; Imipramine inhibits the reaction [TNF protein results in increased abundance of N-palmitoylsphingosine] Imipramine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of TNF protein]; Imipramine promotes the reaction [caryophyllene inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of TNF protein]]
CTD
PMID:15946935 PMID:30529211 PMID:30620895
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Uba52
ubiquitin A-52 residue ribosomal protein fusion product 1
affects expression
ISO
Imipramine affects the expression of UBA52 mRNA
CTD
PMID:18355885
NCBI chr 8:70,960,913...70,963,067
Ensembl chr 8:70,960,913...70,963,451
G
Ugt1a1
UDP glucuronosyltransferase 1 family, polypeptide A1
affects expression
ISO
Imipramine affects the expression of UGT1A1 mRNA
CTD
PMID:18355885
NCBI chr 1:88,139,681...88,147,724
Ensembl chr 1:88,139,681...88,146,719
G
Ugt1a5
UDP glucuronosyltransferase 1 family, polypeptide A5
affects metabolic processing multiple interactions increases glucuronidation
ISO
UGT1A4 protein affects the metabolism of Imipramine Finasteride inhibits the reaction [UGT1A4 protein results in increased glucuronidation of Imipramine] UGT1A4 protein results in increased glucuronidation of Imipramine; UGT1A4 protein SNP results in increased glucuronidation of Imipramine
CTD
PMID:9264550 PMID:14570768 PMID:15286053 PMID:15708967 PMID:25448279
NCBI chr 1:88,093,734...88,147,724
Ensembl chr 1:88,093,734...88,146,719
G
Ugt2a1
UDP glucuronosyltransferase 2 family, polypeptide A1
affects expression
ISO
Imipramine affects the expression of UGT2A1 mRNA
CTD
PMID:18355885
NCBI chr 5:87,607,349...87,638,730
Ensembl chr 5:87,607,349...87,638,730
G
Ugt2b1
UDP glucuronosyltransferase 2 family, polypeptide B1
affects expression
ISO
Imipramine affects the expression of UGT2B1 mRNA
CTD
PMID:18355885
NCBI chr 5:87,064,498...87,074,362
Ensembl chr 5:87,064,497...87,074,389
G
Wipi1
WD repeat domain, phosphoinositide interacting 1
increases expression
ISO
Imipramine results in increased expression of WIPI1 mRNA
CTD
PMID:15342952 PMID:17567588
NCBI chr11:109,464,347...109,502,215
Ensembl chr11:109,464,157...109,502,793
G
Aadat
aminoadipate aminotransferase
affects expression
ISO
Clomipramine affects the expression of AADAT mRNA
CTD
PMID:18355885
NCBI chr 8:60,958,877...60,998,711
Ensembl chr 8:60,958,966...60,998,711
G
Abcb1a
ATP-binding cassette, sub-family B member 1A
affects expression
ISO
Clomipramine affects the expression of ABCB1 mRNA
CTD
PMID:18355885
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
G
Aldh1a1
aldehyde dehydrogenase family 1, subfamily A1
affects expression
ISO
Clomipramine affects the expression of ALDH1A1 mRNA
CTD
PMID:18355885
NCBI chr19:20,469,947...20,620,827
Ensembl chr19:20,470,079...20,620,829
G
Ap1s1
adaptor protein complex AP-1, sigma 1
decreases expression
ISO
Clomipramine results in decreased expression of AP1S1 mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr 5:137,063,852...137,074,917
Ensembl chr 5:137,063,847...137,074,989
G
Apoa4
apolipoprotein A-IV
affects expression
ISO
Clomipramine affects the expression of APOA4 mRNA
CTD
PMID:18355885
NCBI chr 9:46,152,142...46,154,756
Ensembl chr 9:46,151,994...46,154,757
G
Asns
asparagine synthetase
increases expression
ISO
Clomipramine results in increased expression of ASNS mRNA
CTD
PMID:17175557
NCBI chr 6:7,675,169...7,693,209
Ensembl chr 6:7,675,169...7,693,254
G
Bhmt
betaine-homocysteine methyltransferase
affects expression
ISO
Clomipramine affects the expression of BHMT mRNA
CTD
PMID:18355885
NCBI chr13:93,753,399...93,774,266
Ensembl chr13:93,753,183...93,774,469
G
Casp3
caspase 3
multiple interactions increases activity
ISO EXP
Clomipramine results in increased cleavage of and results in increased activity of CASP3 protein; Palmitic Acid promotes the reaction [Clomipramine results in increased activity of CASP3 protein]
CTD
PMID:10487422 PMID:22700542 PMID:28482088
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
G
Casp7
caspase 7
multiple interactions increases activity
ISO
Palmitic Acid promotes the reaction [Clomipramine results in increased activity of CASP7 protein]
CTD
PMID:22700542
NCBI chr19:56,382,640...56,430,780
Ensembl chr19:56,385,561...56,430,776
G
Casp8
caspase 8
increases activity
EXP
Clomipramine results in increased activity of CASP8 protein
CTD
PMID:28482088
NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
G
Casp9
caspase 9
increases activity
EXP
Clomipramine results in increased activity of CASP9 protein
CTD
PMID:28482088
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
G
Cat
catalase
decreases expression
ISO
Clomipramine results in decreased expression of CAT protein
CTD
PMID:1937386
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
G
Cdkn2c
cyclin dependent kinase inhibitor 2C
affects expression
ISO
Clomipramine affects the expression of CDKN2C mRNA
CTD
PMID:18355885
NCBI chr 4:109,518,073...109,523,953
Ensembl chr 4:109,518,073...109,524,386
G
Ces2h
carboxylesterase 2H
affects expression
ISO
Clomipramine affects the expression of CES2 mRNA
CTD
PMID:18355885
NCBI chr 8:105,727,462...105,747,042
Ensembl chr 8:105,727,485...105,747,810
G
Cmtm6
CKLF-like MARVEL transmembrane domain containing 6
affects expression
ISO
Clomipramine affects the expression of CMTM6 mRNA
CTD
PMID:18355885
NCBI chr 9:114,560,184...114,578,412
Ensembl chr 9:114,560,184...114,578,412
G
Cpped1
calcineurin-like phosphoesterase domain containing 1
affects expression
ISO
Clomipramine affects the expression of CPPED1 mRNA
CTD
PMID:18355885
NCBI chr16:11,621,546...11,727,377
Ensembl chr16:11,621,585...11,727,309
G
Crem
cAMP responsive element modulator
affects expression
ISO
Clomipramine affects the expression of CREM mRNA
CTD
PMID:18355885
NCBI chr18:3,263,181...3,337,688
Ensembl chr18:3,266,048...3,337,748
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
decreases activity
ISO
Clomipramine results in decreased activity of CYP1B1 protein
CTD
PMID:33814510
NCBI chr17:80,014,369...80,022,490
Ensembl chr17:80,008,966...80,022,490
G
Cyp2a22
cytochrome P450, family 2, subfamily a, polypeptide 22
affects expression
ISO
Clomipramine affects the expression of CYP2A1 mRNA
CTD
PMID:18355885
NCBI chr 7:26,631,564...26,638,838
Ensembl chr 7:26,631,056...26,638,809
G
Cyp4f14
cytochrome P450, family 4, subfamily f, polypeptide 14
affects expression
ISO
Clomipramine affects the expression of CYP4F2 mRNA
CTD
PMID:18355885
NCBI chr17:33,122,331...33,136,353
Ensembl chr17:33,124,044...33,136,316
G
Dcaf8
DDB1 and CUL4 associated factor 8
affects expression
ISO
Clomipramine affects the expression of DCAF8 mRNA
CTD
PMID:18355885
NCBI chr 1:171,975,574...172,023,959
Ensembl chr 1:171,975,651...172,024,572
G
Depp1
DEPP1 autophagy regulator
increases expression
ISO
Clomipramine results in increased expression of DEPP1 mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr 6:116,627,645...116,629,808
Ensembl chr 6:116,627,570...116,629,755
G
Drd2
dopamine receptor D2
increases expression
ISO
Clomipramine results in increased expression of DRD2 protein
CTD
PMID:20619828
NCBI chr 9:49,251,703...49,319,468
Ensembl chr 9:49,251,927...49,319,477
G
Eif4b
eukaryotic translation initiation factor 4B
affects expression
ISO
Clomipramine affects the expression of EIF4B mRNA
CTD
PMID:18355885
NCBI chr15:101,982,208...102,005,608
Ensembl chr15:101,982,208...102,005,608
G
Ephx1
epoxide hydrolase 1, microsomal
affects expression
ISO
Clomipramine affects the expression of EPHX1 mRNA
CTD
PMID:18355885
NCBI chr 1:180,817,121...180,845,134
Ensembl chr 1:180,803,775...180,848,469
G
Erp29
endoplasmic reticulum protein 29
affects expression
ISO
Clomipramine affects the expression of ERP29 mRNA
CTD
PMID:18355885
NCBI chr 5:121,582,816...121,590,537
Ensembl chr 5:121,566,653...121,590,569
G
Fabp1
fatty acid binding protein 1, liver
increases expression
ISO
Clomipramine results in increased expression of FABP1 mRNA
CTD
PMID:15342952
NCBI chr 6:71,176,863...71,182,018
Ensembl chr 6:71,176,811...71,182,007
G
Fh1
fumarate hydratase 1
multiple interactions
ISO
Clomipramine results in increased activity of and results in increased secretion of FH protein
CTD
PMID:37217012
NCBI chr 1:175,428,944...175,453,201
Ensembl chr 1:175,427,940...175,453,201
G
Fndc4
fibronectin type III domain containing 4
increases expression decreases expression
ISO
Clomipramine results in increased expression of FNDC4 mRNA Clomipramine results in decreased expression of FNDC4 mRNA
CTD
PMID:17175557
NCBI chr 5:31,449,589...31,453,279
Ensembl chr 5:31,449,586...31,453,424
G
Gckr
glucokinase regulatory protein
affects expression
ISO
Clomipramine affects the expression of GCKR mRNA
CTD
PMID:18355885
NCBI chr 5:31,454,594...31,484,646
Ensembl chr 5:31,454,787...31,484,658
G
Gdpd3
glycerophosphodiester phosphodiesterase domain containing 3
increases expression
ISO
Clomipramine results in increased expression of GDPD3 mRNA
CTD
PMID:17175557
NCBI chr 7:126,365,586...126,374,817
Ensembl chr 7:126,365,506...126,374,821
G
Gls2
glutaminase 2 (liver, mitochondrial)
affects expression
ISO
Clomipramine affects the expression of GLS2 mRNA
CTD
PMID:18355885
NCBI chr10:128,030,504...128,045,873
Ensembl chr10:128,030,326...128,045,873
G
Got2
glutamatic-oxaloacetic transaminase 2, mitochondrial
affects expression
ISO
Clomipramine affects the expression of GOT2 mRNA
CTD
PMID:18355885
NCBI chr 8:96,590,761...96,615,029
Ensembl chr 8:96,590,762...96,615,175
G
Gpt
glutamic pyruvic transaminase, soluble
multiple interactions increases export
ISO
Clomipramine results in increased activity of and results in increased secretion of GPT protein Clomipramine results in increased export of GPT protein
CTD
PMID:37217012
NCBI chr15:76,580,926...76,583,875
Ensembl chr15:76,579,916...76,583,886
G
Grb14
growth factor receptor bound protein 14
affects expression
ISO
Clomipramine affects the expression of GRB14 mRNA
CTD
PMID:18355885
NCBI chr 2:64,742,820...64,853,143
Ensembl chr 2:64,742,820...64,855,331
G
Gstp1
glutathione S-transferase, pi 1
decreases activity
ISO
Clomipramine results in decreased activity of GSTP1 protein
CTD
PMID:15094841
NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985
G
Hal
histidine ammonia lyase
affects expression
ISO
Clomipramine affects the expression of HAL mRNA
CTD
PMID:18355885
NCBI chr10:93,324,630...93,352,623
Ensembl chr10:93,324,630...93,355,166
G
Hmgb2
high mobility group box 2
affects expression
ISO
Clomipramine affects the expression of HMGB2 mRNA
CTD
PMID:18355885
NCBI chr 8:57,964,877...57,969,033
Ensembl chr 8:57,964,941...57,969,033
G
Hmgcs1
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1
increases expression
ISO
Clomipramine results in increased expression of HMGCS1 mRNA
CTD
PMID:16324787
NCBI chr13:120,151,887...120,169,796
Ensembl chr13:120,151,915...120,169,796
G
Hpn
hepsin
increases expression
ISO
Clomipramine results in increased expression of HPN mRNA
CTD
PMID:15342952
NCBI chr 7:30,798,150...30,814,751
Ensembl chr 7:30,798,150...30,814,715
G
Htr2c
5-hydroxytryptamine (serotonin) receptor 2C
affects binding increases expression
ISO
Clomipramine binds to HTR2C protein Clomipramine results in increased expression of HTR2C protein
CTD
PMID:18083778 PMID:20619828
NCBI chr X:145,745,509...145,980,273
Ensembl chr X:145,745,509...145,980,273
G
Il1a
interleukin 1 alpha
multiple interactions
ISO
[IL6 protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to Clomipramine
CTD
PMID:19362101
NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892
G
Il33
interleukin 33
affects expression
ISO
Clomipramine affects the expression of IL33 mRNA
CTD
PMID:18355885
NCBI chr19:29,902,513...29,938,118
Ensembl chr19:29,902,514...29,938,118
G
Il6
interleukin 6
multiple interactions
ISO
[IL6 protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to Clomipramine
CTD
PMID:19362101
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Inhbe
inhibin beta-E
increases expression
ISO
Clomipramine results in increased expression of INHBE mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr10:127,185,271...127,187,717
Ensembl chr10:127,184,726...127,190,280
G
Kcnh2
potassium voltage-gated channel, subfamily H (eag-related), member 2
multiple interactions
ISO
Clomipramine inhibits the reaction [KCNH2 protein results in increased transport of Thallium]
CTD
PMID:21158687
NCBI chr 5:24,524,583...24,556,671
Ensembl chr 5:24,524,587...24,556,602
G
Lox
lysyl oxidase
affects expression
ISO
Clomipramine affects the expression of LOX mRNA
CTD
PMID:18355885
NCBI chr18:52,649,132...52,662,939
Ensembl chr18:52,649,139...52,662,939
G
Lss
lanosterol synthase
increases expression
ISO
Clomipramine results in increased expression of LSS mRNA
CTD
PMID:15342952
NCBI chr10:76,367,303...76,392,973
Ensembl chr10:76,367,422...76,392,972
G
Macroh2a1
macroH2A.1 histone
affects expression
ISO
Clomipramine affects the expression of MACROH2A1 mRNA
CTD
PMID:18355885
NCBI chr13:56,221,435...56,283,439
Ensembl chr13:56,221,432...56,284,174
G
Manba
mannosidase, beta A, lysosomal
affects expression
ISO
Clomipramine affects the expression of MANBA mRNA
CTD
PMID:18355885
NCBI chr 3:135,191,367...135,277,165
Ensembl chr 3:135,191,372...135,277,165
G
Mlx
MAX-like protein X
affects expression
ISO
Clomipramine affects the expression of MLX mRNA
CTD
PMID:18355885
NCBI chr11:100,978,116...100,983,033
Ensembl chr11:100,978,103...100,983,033
G
Mrps18b
mitochondrial ribosomal protein S18B
affects expression
ISO
Clomipramine affects the expression of MRPS18B mRNA
CTD
PMID:18355885
NCBI chr17:36,221,272...36,227,332
Ensembl chr17:36,221,271...36,227,281
G
Msmo1
methylsterol monoxygenase 1
affects expression
ISO
Clomipramine affects the expression of MSMO1 mRNA
CTD
PMID:18355885
NCBI chr 8:65,171,157...65,186,822
Ensembl chr 8:65,171,173...65,186,826
G
Nr0b2
nuclear receptor subfamily 0, group B, member 2
increases expression
ISO
Clomipramine results in increased expression of NR0B2 mRNA
CTD
PMID:17175557
NCBI chr 4:133,280,687...133,283,997
Ensembl chr 4:133,280,687...133,283,847
G
Nrep
neuronal regeneration related protein
affects expression
ISO
Clomipramine affects the expression of NREP mRNA
CTD
PMID:18355885
NCBI chr18:33,570,072...33,597,444
Ensembl chr18:33,570,072...33,597,082
G
Ntrk2
neurotrophic tyrosine kinase, receptor, type 2
increases phosphorylation
EXP
Clomipramine results in increased phosphorylation of NTRK2 protein
CTD
PMID:22396798
NCBI chr13:58,954,363...59,281,782
Ensembl chr13:58,954,383...59,281,784
G
Nupr1
nuclear protein transcription regulator 1
increases expression
ISO
Clomipramine results in increased expression of NUPR1 mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr 7:126,222,418...126,224,642
Ensembl chr 7:126,222,421...126,230,033
G
Oaf
out at first homolog
affects expression
ISO
Clomipramine affects the expression of OAF mRNA
CTD
PMID:18355885
NCBI chr 9:43,132,575...43,151,113
Ensembl chr 9:43,132,532...43,151,208
G
Parp1
poly (ADP-ribose) polymerase family, member 1
increases cleavage
ISO
Clomipramine results in increased cleavage of PARP1 protein
CTD
PMID:10487422
NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
G
Pcx
pyruvate carboxylase
affects expression
ISO
Clomipramine affects the expression of PC mRNA
CTD
PMID:18355885
NCBI chr19:4,560,500...4,671,780
Ensembl chr19:4,560,500...4,671,780
G
Pecr
peroxisomal trans-2-enoyl-CoA reductase
affects expression
ISO
Clomipramine affects the expression of PECR mRNA
CTD
PMID:18355885
NCBI chr 1:72,298,331...72,323,480
Ensembl chr 1:72,298,326...72,323,473
G
Phyh
phytanoyl-CoA hydroxylase
increases expression
ISO
Clomipramine results in increased expression of PHYH mRNA
CTD
PMID:15342952
NCBI chr 2:4,923,807...4,943,554
Ensembl chr 2:4,923,830...4,943,541
G
Por
cytochrome p450 oxidoreductase
affects expression
ISO
Clomipramine affects the expression of POR mRNA
CTD
PMID:18355885
NCBI chr 5:135,698,894...135,764,180
Ensembl chr 5:135,698,887...135,764,180
G
Prl
prolactin
affects secretion increases secretion multiple interactions increases expression
ISO
Clomipramine affects the secretion of PRL protein Clomipramine results in increased secretion of PRL protein SLC6A4 polymorphism inhibits the reaction [Clomipramine affects the secretion of PRL protein] Clomipramine results in increased expression of PRL protein
CTD
PMID:3602989 PMID:7930386 PMID:17000009 PMID:19698552
NCBI chr13:27,241,553...27,249,187
Ensembl chr13:27,241,553...27,249,188
G
Proc
protein C
increases expression
ISO
Clomipramine results in increased expression of PROC protein
CTD
PMID:17891354
NCBI chr18:32,256,179...32,272,623
Ensembl chr18:32,256,179...32,272,623
G
Rbl2
RB transcriptional corepressor like 2
affects expression
ISO
Clomipramine affects the expression of RBL2 mRNA
CTD
PMID:18355885
NCBI chr 8:91,796,685...91,850,472
Ensembl chr 8:91,796,685...91,850,472
G
Scd2
stearoyl-Coenzyme A desaturase 2
increases expression
ISO
Clomipramine results in increased expression of SCD mRNA
CTD
PMID:16324787
NCBI chr19:44,282,115...44,295,303
Ensembl chr19:44,282,113...44,295,303
G
Serpina3b
serine (or cysteine) peptidase inhibitor, clade A, member 3B
increases expression
ISO
Clomipramine results in increased expression of SERPINA3 mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr12:104,094,245...104,105,805
Ensembl chr12:104,094,255...104,105,804
G
Sh3gl3
SH3-domain GRB2-like 3
affects expression
ISO
Clomipramine affects the expression of SH3GL3 mRNA
CTD
PMID:18355885
NCBI chr 7:81,824,581...81,956,618
Ensembl chr 7:81,823,588...81,956,627
G
Slc22a2
solute carrier family 22 (organic cation transporter), member 2
multiple interactions
ISO
Clomipramine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
CTD
PMID:21599003
NCBI chr17:12,803,076...12,847,376
Ensembl chr17:12,803,019...12,847,375
G
Slc2a3
solute carrier family 2 (facilitated glucose transporter), member 3
decreases expression
ISO
Clomipramine results in decreased expression of SLC2A3 mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr 6:122,704,783...122,779,149
Ensembl chr 6:122,704,768...122,778,599
G
Slc6a4
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
multiple interactions
ISO
Clomipramine binds to and results in decreased activity of SLC6A4 protein; SLC6A4 polymorphism inhibits the reaction [Clomipramine affects the secretion of PRL protein]
CTD
PMID:16272152 PMID:17000009
NCBI chr11:76,889,423...76,923,169
Ensembl chr11:76,889,429...76,923,166
G
Slc6a6
solute carrier family 6 (neurotransmitter transporter, taurine), member 6
affects expression
ISO
Clomipramine affects the expression of SLC6A6 mRNA
CTD
PMID:18355885
NCBI chr 6:91,661,031...91,736,044
Ensembl chr 6:91,661,034...91,736,047
G
Slco1a4
solute carrier organic anion transporter family, member 1a4
affects expression
ISO
Clomipramine affects the expression of SLCO1A4 mRNA
CTD
PMID:18355885
NCBI chr 6:141,751,164...141,802,011
Ensembl chr 6:141,751,166...141,801,925
G
Srebf1
sterol regulatory element binding transcription factor 1
multiple interactions
ISO
Clomipramine results in increased cleavage of and results in increased activity of SREBF1 protein
CTD
PMID:16324787
NCBI chr11:60,089,910...60,113,407
Ensembl chr11:60,089,915...60,113,407
G
Srebf2
sterol regulatory element binding factor 2
multiple interactions
ISO
Clomipramine results in increased cleavage of and results in increased activity of SREBF2 protein
CTD
PMID:16324787
NCBI chr15:82,031,455...82,089,580
Ensembl chr15:82,031,382...82,089,580
G
St13
suppression of tumorigenicity 13
affects expression
ISO
Clomipramine affects the expression of ST13 mRNA
CTD
PMID:18355885
NCBI chr15:81,247,869...81,284,278
Ensembl chr15:81,247,870...81,284,278
G
Stbd1
starch binding domain 1
affects expression
ISO
Clomipramine affects the expression of STBD1 mRNA
CTD
PMID:18355885
NCBI chr 5:92,750,910...92,754,438
Ensembl chr 5:92,750,900...92,754,438
G
Stmn1
stathmin 1
affects expression
ISO
Clomipramine affects the expression of STMN1 mRNA
CTD
PMID:18355885
NCBI chr 4:134,195,631...134,201,154
Ensembl chr 4:134,195,631...134,201,154
G
Tac1
tachykinin 1
decreases expression
ISO
Clomipramine results in decreased expression of TAC1 protein
CTD
PMID:8955926
NCBI chr 6:7,555,061...7,562,978
Ensembl chr 6:7,554,879...7,565,834
G
Tagln
transgelin
decreases expression
ISO
Clomipramine results in decreased expression of TAGLN mRNA
CTD
PMID:17175557
NCBI chr 9:45,840,926...45,847,356
Ensembl chr 9:45,840,917...45,847,356
G
Tex261
testis expressed gene 261
affects expression
ISO
Clomipramine affects the expression of TEX261 mRNA
CTD
PMID:18355885
NCBI chr 6:83,745,863...83,752,804
Ensembl chr 6:83,745,867...83,752,795
G
Thra
thyroid hormone receptor alpha
multiple interactions
ISO
Clomipramine binds to and results in decreased activity of THRA protein
CTD
PMID:25752796
NCBI chr11:98,631,539...98,659,832
Ensembl chr11:98,631,464...98,659,832
G
Timm10b
translocase of inner mitochondrial membrane 10B
affects expression
ISO
Clomipramine affects the expression of TIMM10B mRNA
CTD
PMID:18355885
NCBI chr 7:105,289,652...105,304,955
Ensembl chr 7:105,289,263...105,292,844 Ensembl chr 7:105,289,263...105,292,844
G
Tnf
tumor necrosis factor
multiple interactions
ISO
[IL6 protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to Clomipramine
CTD
PMID:19362101
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Uba52
ubiquitin A-52 residue ribosomal protein fusion product 1
affects expression
ISO
Clomipramine affects the expression of UBA52 mRNA
CTD
PMID:18355885
NCBI chr 8:70,960,913...70,963,067
Ensembl chr 8:70,960,913...70,963,451
G
Ugt1a1
UDP glucuronosyltransferase 1 family, polypeptide A1
affects expression
ISO
Clomipramine affects the expression of UGT1A1 mRNA
CTD
PMID:18355885
NCBI chr 1:88,139,681...88,147,724
Ensembl chr 1:88,139,681...88,146,719
G
Ugt2a1
UDP glucuronosyltransferase 2 family, polypeptide A1
affects expression
ISO
Clomipramine affects the expression of UGT2A1 mRNA
CTD
PMID:18355885
NCBI chr 5:87,607,349...87,638,730
Ensembl chr 5:87,607,349...87,638,730
G
Ugt2b1
UDP glucuronosyltransferase 2 family, polypeptide B1
affects expression
ISO
Clomipramine affects the expression of UGT2B1 mRNA
CTD
PMID:18355885
NCBI chr 5:87,064,498...87,074,362
Ensembl chr 5:87,064,497...87,074,389
G
Wipi1
WD repeat domain, phosphoinositide interacting 1
increases expression
ISO
Clomipramine results in increased expression of WIPI1 mRNA
CTD
PMID:15342952 PMID:17175557
NCBI chr11:109,464,347...109,502,215
Ensembl chr11:109,464,157...109,502,793
G
Slc22a2
solute carrier family 22 (organic cation transporter), member 2
multiple interactions
ISO
Trimipramine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
CTD
PMID:21599003
NCBI chr17:12,803,076...12,847,376
Ensembl chr17:12,803,019...12,847,375
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all